Chlorothiazide sodium side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Burkholderia test positive
2. Asthenia (weakness)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Alanine aminotransferase increased
2. Arrhythmia (irregular heartbeat)
3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
4. Blood calcium abnormal
5. Blood calcium decreased
6. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
7. Death
8. Dry skin
9. Infection
10. Injection site calcification

female:

1. Acute respiratory failure
2. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
3. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
5. Blood calcium decreased
6. Bone density decreased
7. Infection
8. Lethargy (tiredness)

male:

1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
2. Bone density decreased
3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
4. Death
5. Dry skin
6. Nausea (feeling of having an urge to vomit)
7. Burkholderia test positive
8. Cardiac disorder
9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
10. Acute respiratory failure

0-1:

1. Acute respiratory failure
2. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
4. Blood calcium abnormal
5. Death

2-9:

1. Acute respiratory failure
2. Alanine aminotransferase increased
3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

10-19:

1. Cardiac disorder
2. Arrhythmia (irregular heartbeat)

20-29:

n/a

30-39:

n/a

40-49:

1. Bone density decreased

50-59:

1. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)
2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
3. Dry skin

60+:

1. Bone density decreased
2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)